miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers

• Liqin Du,

  Affiliations Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, Texas, United States of America, Department of Cellular and Structural Biology, UT Health Science Center at San Antonio, San Antonio, Texas, United States of America

  ⨯
• Maria C. Subauste,

  Affiliation McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Christopher DeSevo,

  Affiliation Division of Basic Sciences, Southwestern Graduate School of Biomedical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Zhenze Zhao,

  Affiliation Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, Texas, United States of America

  ⨯
• Michael Baker,

  Affiliation Division of Basic Sciences, Southwestern Graduate School of Biomedical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Robert Borkowski,

  Affiliation Division of Basic Sciences, Southwestern Graduate School of Biomedical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Jeoffrey J. Schageman,

  Affiliation McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Rachel Greer,

  Affiliation Division of Basic Sciences, Southwestern Graduate School of Biomedical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Chin-Rang Yang,

  Affiliation Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Milind Suraokar,

  Affiliation Department of Pathology, UT MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Ignacio I. Wistuba,

  Affiliations Department of Pathology, UT MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Adi F. Gazdar,

  Affiliations Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America, Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• John D. Minna,

  Affiliations Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America, Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas, United States of America, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, United States of America, Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Alexander Pertsemlidis

  * E-mail: pertsemlidis@uthscsa.edu

  Affiliations Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, Texas, United States of America, Department of Cellular and Structural Biology, UT Health Science Center at San Antonio, San Antonio, Texas, United States of America, Department of Pediatrics, UT Health Science Center at San Antonio, San Antonio, Texas, United States of America

  ⨯